Biocon Bilan de santé
Santé financière contrôle des critères 2/6
Biocon possède un total de capitaux propres de ₹267.2B et une dette totale de ₹161.5B, ce qui porte son ratio d'endettement à 60.4%. Son actif total et son passif total sont ₹571.3B et de ₹304.1B. L'EBIT de Biocon est ₹15.9B ce qui fait que son ratio de couverture des intérêts 2. Elle dispose de liquidités et de placements à court terme de ₹26.5B.
Informations clés
60.4%
Ratio d'endettement
₹161.50b
Dette
| Ratio de couverture des intérêts | 2x |
| Argent liquide | ₹26.50b |
| Fonds propres | ₹267.20b |
| Total du passif | ₹304.08b |
| Total des actifs | ₹571.28b |
Mises à jour récentes de la santé financière
These 4 Measures Indicate That Biocon (NSE:BIOCON) Is Using Debt Extensively
Sep 20
Is Biocon (NSE:BIOCON) A Risky Investment?
Jun 11These 4 Measures Indicate That Biocon (NSE:BIOCON) Is Using Debt Extensively
Nov 13Is Biocon (NSE:BIOCON) Using Too Much Debt?
Jul 02Here's Why Biocon (NSE:BIOCON) Can Manage Its Debt Responsibly
Feb 26Is Biocon (NSE:BIOCON) Using Too Much Debt?
Jul 13Recent updates
Here's What Analysts Are Forecasting For Biocon Limited (NSE:BIOCON) After Its Second-Quarter Results
Nov 02Why Investors Shouldn't Be Surprised By Biocon Limited's (NSE:BIOCON) Low P/E
Nov 01Do Biocon's (NSE:BIOCON) Earnings Warrant Your Attention?
Oct 14These 4 Measures Indicate That Biocon (NSE:BIOCON) Is Using Debt Extensively
Sep 20Biocon Limited's (NSE:BIOCON) Earnings Haven't Escaped The Attention Of Investors
Jun 29Is Biocon (NSE:BIOCON) A Risky Investment?
Jun 11Biocon (NSE:BIOCON) Is Reducing Its Dividend To ₹0.50
Jun 11Biocon's (NSE:BIOCON) Promising Earnings May Rest On Soft Foundations
May 24Biocon's (NSE:BIOCON) Dividend Is Being Reduced To ₹0.50
May 23Is Now The Time To Put Biocon (NSE:BIOCON) On Your Watchlist?
Mar 20Biocon Limited Just Beat EPS By 240%: Here's What Analysts Think Will Happen Next
Feb 12Biocon Limited's (NSE:BIOCON) Intrinsic Value Is Potentially 18% Below Its Share Price
Jan 23Shareholders Should Be Pleased With Biocon Limited's (NSE:BIOCON) Price
Jan 03These 4 Measures Indicate That Biocon (NSE:BIOCON) Is Using Debt Extensively
Nov 13Estimating The Intrinsic Value Of Biocon Limited (NSE:BIOCON)
Aug 03Biocon (NSE:BIOCON) Will Pay A Larger Dividend Than Last Year At ₹1.50
Jul 03Is Biocon (NSE:BIOCON) Using Too Much Debt?
Jul 02Biocon's (NSE:BIOCON) Dividend Will Be Increased To ₹1.50
May 26Estimating The Fair Value Of Biocon Limited (NSE:BIOCON)
Mar 28Here's Why Biocon (NSE:BIOCON) Can Manage Its Debt Responsibly
Feb 26Biocon Limited (NSE:BIOCON) Shares Could Be 24% Above Their Intrinsic Value Estimate
Dec 17Is There An Opportunity With Biocon Limited's (NSE:BIOCON) 46% Undervaluation?
Sep 05Is Biocon (NSE:BIOCON) Using Too Much Debt?
Jul 13Biocon Limited (NSE:BIOCON) Shares Could Be 20% Below Their Intrinsic Value Estimate
May 26Analyse de la situation financière
Passif à court terme: Les actifs à court terme de BIOCON ( ₹151.5B ) ne couvrent pas ses passifs à court terme ( ₹158.1B ).
Passif à long terme: Les actifs à court terme de BIOCON ( ₹151.5B ) dépassent ses passifs à long terme ( ₹146.0B ).
Historique et analyse du ratio d'endettement
Niveau d'endettement: Le ratio dette nette/capitaux propres de BIOCON ( 50.5% ) est considéré comme élevé.
Réduire la dette: Le ratio d'endettement de BIOCON est passé de 30.5% à 60.4% au cours des 5 dernières années.
Couverture de la dette: La dette de BIOCON est bien couverte par le flux de trésorerie opérationnel ( 25% ).
Couverture des intérêts: Les paiements d'intérêts de BIOCON sur sa dette ne sont pas bien couverts par l'EBIT ( 2 x couverture).